- 专利标题： Halogenated salicylanilides for treating Clostridium infections
-
申请号： US17091691申请日： 2020-11-06
-
公开(公告)号： US11529361B2公开(公告)日： 2022-12-20
- 发明人: Morten Otto Alexander Sommer , Rasmus Vendler Toft-Kehler , Daniel Jean Jacques Simon
- 申请人： UNION therapeutics A/S
- 申请人地址： DK Hellerup
- 专利权人： UNION therapeutics A/S
- 当前专利权人： UNION therapeutics A/S
- 当前专利权人地址： DK Hellerup
- 代理机构： Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
- 优先权： GB1509326.3 20150529
- 主分类号： A61K31/609
- IPC分类号： A61K31/609 ; A61K31/612 ; A61P31/04 ; A61K45/06
摘要：
The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection in a subject caused by Clostridium bacteria, particularly a C. difficile infection. The halogenated salicylanilides are expected to be useful in the treatment of C. difficile associated diseases including C. difficile associated diarrhoea and C. difficile associated colitis.
公开/授权文献
信息查询
